Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversidad de La Frontera
About this trial
CO-CREATION-HF aims to evaluate the effectiveness of a comprehensive and hybrid cardiac rehabilitation model compared to supervised exercise alone.
Eligibility criteria
Qualifiers
Adult patients with HF of New York Heart Association functional class II or III.
Meets HF diagnostic criteria of Guidelines
On optimal tolerated medical therapy.
Deemed by the treating physician as stable for at least 1 month.
Disqualifiers
Chronic kidney disease with glomerular filtration rate < 20 mL/min.
Decompensated thyroid disease.
End-stage liver failure or Child-Pugh C.
Cardiac device or cardiac surgery in the previous month or planned in the next 3 months.
Trial design
Treatments tested in this trial
- Comprehensive Initial Assessment
- Continuous evaluation
- Interval Exercise
- Psychosocial support
- Diet management
- Resistance exercise
- Continuous exercise
- Initial Assessment
Treatment groups
152 Participants
are divided into 2 treatment groupsLocations
4Complejo Hospitalario San José Santiago Chile
Hospital Clínico Universidad de Chile Santiago Chile
Hospital San Borja Arriarán Santiago Chile
Universidad de La Frontera Temuco Chile
Sponsors and collaborators
Universidad de La Frontera
Lead sponsor
University of Chile
Collaborator
Source ClinicalTrials.gov